QV Bioelectronics
World-first implantable brain cancer therapy
Alderley Park, United Kingdom · Founded 2018 · $7.7M raised
- Headquarters
- Alderley Park
- Founded
- 2018
- Business Model
- B2B
- Website
- qvbio.co.uk
- Total Funding
- $7.7M
- Last Round
- $5.6M Series AJan 2026
- Rounds
- 2
About
VC-backed medical device startup developing GRACE (Glioma Resection Advanced Cavity Electric Field Therapy), an implantable electric field therapy device to treat glioblastoma (aggressive brain tumors). Device delivers continuous therapeutic electric fields to surgical cavity post-resection. Founders: Dr Christopher Bullock (CEO, biomedical engineer) and Dr Richard Fu (neurosurgeon).
Summary
QV Bioelectronics is a company based in Alderley Park, United Kingdom, founded in 2018. It has raised $7.7M in total across 2 rounds, most recently a $5.6M Series A round in Jan 2026. Investors include PXN Ventures, Science Angel Syndicate and Fink Family Office.
Tech & App Stack
4 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.